CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+16.96%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$379M
AUM Growth
+$379M
(+32%)
Cap. Flow
+$75.9M
Cap. Flow
% of AUM
20%
Top 10 Holdings %
Top 10 Hldgs %
63.93%
Holding
34
New
5
Increased
14
Reduced
3
Closed
5
Top Buys
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$26.1M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$16.3M |
| 3 |
Merus
MRUS
|
$15.8M |
| 4 |
Tenaya Therapeutics
TNYA
|
$10.6M |
| 5 |
Aclaris Therapeutics
ACRS
|
$9.38M |
Top Sells
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$14.9M |
| 2 |
Astria Therapeutics
ATXS
|
$12.2M |
| 3 |
MacroGenics
MGNX
|
$10.6M |
| 4 |
ESSA Pharma
EPIX
|
$8.05M |
| 5 |
Mersana Therapeutics
MRSN
|
$5.83M |
Sector Composition
| 1 | Healthcare | 92.47% |
| 2 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVA
26
Inventiva
IVA
$730M
| $3.72M | 0.98% |
262,658
| – | – |
|
|
BLSA
27
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $2.49M | 0.66% |
250,000
| – | – |
|
|
28
Astria Therapeutics
ATXS
$366M
| $2.12M | 0.56% |
239,270
-1,377,730
| -85% | -$12.2M |
|
29
ARS Pharmaceuticals
SPRY
$1.1B
| $969K | 0.26% |
97,143
| – | – |
|
|
30
ESSA Pharma
EPIX
$11.2M
| – | – |
-281,911
| Closed | -$8.05M |
|
31
Seres Therapeutics
MCRB
$170M
| – | – |
-145,453
| Closed | -$3.47M |
|
|
32
MacroGenics
MGNX
$118M
| – | – |
-393,850
| Closed | -$10.6M |
|
|
33
Mersana Therapeutics
MRSN
$36.4M
| – | – |
-429,228
| Closed | -$5.83M |
|
|
CNST
34
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – |
-440,869
| Closed | -$14.9M |
|